165 related articles for article (PubMed ID: 38365720)
1. A regulatory element associated to NAFLD in the promoter of DIO1 controls LDL-C, HDL-C and triglycerides in hepatic cells.
Castillejo-López C; Bárcenas-Walls JR; Cavalli M; Larsson A; Wadelius C
Lipids Health Dis; 2024 Feb; 23(1):48. PubMed ID: 38365720
[TBL] [Abstract][Full Text] [Related]
2. Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
Handelman SK; Puentes YM; Kuppa A; Chen Y; Du X; Feitosa MF; Palmer ND; Speliotes EK
Hepatol Commun; 2022 Nov; 6(11):3120-3131. PubMed ID: 36098472
[TBL] [Abstract][Full Text] [Related]
3. Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling.
Liu J; Hernandez-Ono A; Graham MJ; Galton VA; Ginsberg HN
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1356-66. PubMed ID: 27150392
[TBL] [Abstract][Full Text] [Related]
4. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.
Zhang M; Yuan Y; Wang Q; Li X; Men J; Lin M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291215
[TBL] [Abstract][Full Text] [Related]
5. Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression.
Bruinstroop E; Zhou J; Tripathi M; Yau WW; Boelen A; Singh BK; Yen PM
Mol Metab; 2021 Nov; 53():101266. PubMed ID: 34098145
[TBL] [Abstract][Full Text] [Related]
6. Multiple Hepatic Regulatory Variants at the GALNT2 GWAS Locus Associated with High-Density Lipoprotein Cholesterol.
Roman TS; Marvelle AF; Fogarty MP; Vadlamudi S; Gonzalez AJ; Buchkovich ML; Huyghe JR; Fuchsberger C; Jackson AU; Wu Y; Civelek M; Lusis AJ; Gaulton KJ; Sethupathy P; Kangas AJ; Soininen P; Ala-Korpela M; Kuusisto J; Collins FS; Laakso M; Boehnke M; Mohlke KL
Am J Hum Genet; 2015 Dec; 97(6):801-15. PubMed ID: 26637976
[TBL] [Abstract][Full Text] [Related]
7. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1.
Zhou JP; Ren YD; Xu QY; Song Y; Zhou F; Chen MY; Liu JJ; Chen LG; Pan JS
Biomed Res Int; 2020; 2020():4087928. PubMed ID: 31998789
[TBL] [Abstract][Full Text] [Related]
8.
Cannon ME; Duan Q; Wu Y; Zeynalzadeh M; Xu Z; Kangas AJ; Soininen P; Ala-Korpela M; Civelek M; Lusis AJ; Kuusisto J; Collins FS; Boehnke M; Tang H; Laakso M; Li Y; Mohlke KL
G3 (Bethesda); 2017 Sep; 7(9):3217-3227. PubMed ID: 28754724
[TBL] [Abstract][Full Text] [Related]
9. Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol.
Khetarpal SA; Edmondson AC; Raghavan A; Neeli H; Jin W; Badellino KO; Demissie S; Manning AK; DerOhannessian SL; Wolfe ML; Cupples LA; Li M; Kathiresan S; Rader DJ
PLoS Genet; 2011 Dec; 7(12):e1002393. PubMed ID: 22174694
[TBL] [Abstract][Full Text] [Related]
10. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
[TBL] [Abstract][Full Text] [Related]
11. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
[TBL] [Abstract][Full Text] [Related]
12. Role of Inflammatory Factors in Mediating the Effect of Lipids on Nonalcoholic Fatty Liver Disease: A Two-Step, Multivariable Mendelian Randomization Study.
Chen J; Zhou H; Jin H; Liu K
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297117
[TBL] [Abstract][Full Text] [Related]
13. Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.
Harrison SC; Holmes MV; Burgess S; Asselbergs FW; Jones GT; Baas AF; van 't Hof FN; de Bakker PIW; Blankensteijn JD; Powell JT; Saratzis A; de Borst GJ; Swerdlow DI; van der Graaf Y; van Rij AM; Carey DJ; Elmore JR; Tromp G; Kuivaniemi H; Sayers RD; Samani NJ; Bown MJ; Humphries SE
JAMA Cardiol; 2018 Jan; 3(1):26-33. PubMed ID: 29188294
[TBL] [Abstract][Full Text] [Related]
14. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
Namjou B; Lingren T; Huang Y; Parameswaran S; Cobb BL; Stanaway IB; Connolly JJ; Mentch FD; Benoit B; Niu X; Wei WQ; Carroll RJ; Pacheco JA; Harley ITW; Divanovic S; Carrell DS; Larson EB; Carey DJ; Verma S; Ritchie MD; Gharavi AG; Murphy S; Williams MS; Crosslin DR; Jarvik GP; Kullo IJ; Hakonarson H; Li R; ; Xanthakos SA; Harley JB
BMC Med; 2019 Jul; 17(1):135. PubMed ID: 31311600
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
17. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
18. Ethanol-mediated upregulation of APOA1 gene expression in HepG2 cells is independent of de novo lipid biosynthesis.
Khodja Y; Samuels ME
Lipids Health Dis; 2020 Jun; 19(1):144. PubMed ID: 32563265
[TBL] [Abstract][Full Text] [Related]
19. Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement.
Zhu Z; Yang N; Fu H; Yuan G; Chen Y; Du T; Zhou X
Front Endocrinol (Lausanne); 2022; 13():1002099. PubMed ID: 36187115
[TBL] [Abstract][Full Text] [Related]
20. MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study.
Hsiao PJ; Lee MY; Wang YT; Jiang HJ; Lin PC; Yang YH; Kuo KK
BMC Med Genet; 2015 Oct; 16():93. PubMed ID: 26458397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
